- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05826132
Digital Mental Health Care for COVID-19 High-Risk Populations - Phase 2
The mental health consequences of the COVID-19 (Coronavirus Disease of 2019) pandemic are likely to be vast, exceeding the capacity of mental health services and delaying treatment for people in need, with devastating consequences for those affected. Emerging data suggest that frontline health workers (e.g. physicians, nurses, emergency medical technicians) and essential workers (in industries such as energy, and food products and services) face particular risks for mental health problems during and after the COVID-19 outbreak. Additionally, our previous findings have shown that among these higher risk individuals, young adults and women reported greater levels of clinical symptoms.
To address the unprecedented mental health needs during and as a result of the COVID-19 pandemic this study will develop and test novel, cost-effective and scalable, digitally-delivered mental health interventions, and will test this approach by focusing on health care workers and other essential workers with an eye toward the young adult portion of this population.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Stigma towards mental health care is a profound obstacle that interferes with individuals seeking these services. Research suggests that interventions that are based on social contact are the most efficient way to reduce stigma. A previous phase of this study also showed that participants of certain minority groups (Black participants and female participants) were more impacted by the intervention when it was delivered by a presenter who shared their demographic characteristics. By utilizing an online video intervention, this study aims to address stigma and empower essential workers (healthcare and non-healthcare workers) to seek treatment for mental health issues. As a secondary aim, this study will examine whether the intervention results in behavioral changes in help-seeking. The investigators will study this by adding a link to a database of mental health care providers and measuring the number of times participants click on the link. A total of 1,400 young adult members of these high-risk groups will be recruited to participate in a randomized controlled trial (RCT) testing the efficacy of the intervention.
The intervention will consist of brief videos in which empowered members of the respective high-risk group (presented by actors) share their COVID-19 related mental health problems and describe how they were able to confront their mental health problems, which in turn helped them seek mental health care. Within each high-risk group, individuals will first be randomized to receive either the video intervention, with content adjusted to the presenter's young adult, female, Latino identity, the intervention video without any identity-based content, or non-intervention control.
The study will randomize participants within each high-risk group into one of three arms:
1) Adjusted Content Intervention Video: 2-3-minute video in which an empowered essential worker protagonist shares her COVID-19 related mental health problems and describes how she was able to confront her mental health problems and pursuit of mental health care, using language that speaks to the specific experience of being a young Latina woman; 2) Non-Adjusted Intervention Video: 2-3-minute video in which an empowered essential worker protagonist shares her COVID-19 related mental health problems and describes how she was able to confront her mental health problems and pursuit of mental health care, without any language alluding to her particular identity characteristics; 3) No Intervention (Control Arm): Participants randomized to this arm will view a video of the presenter describing daily activities, without mention of COVID-19 or mental health. Thirty days following the intervention, a follow-up assessment will examine longer-term effects.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yuval Neria, PhD
- Phone Number: 9144980412
- Email: Yuval.Neria@nyspi.columbia.edu
Study Contact Backup
- Name: Doron Amsalem, MD
- Phone Number: 9294048802
- Email: doron.amsalem@nyspi.columbia.edu
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- New York State Psychiatric Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Essential worker
- Ages 18-35
- English-speaking, able to provide consent
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Adjusted Content Intervention Video
Participants will watch a 2-3-minute video in which an empowered essential worker protagonist shares her COVID-19 related mental health problems and describes how she was able to confront her mental health problems and pursuit of mental health care, using language that speaks to the specific experience of being a young Latina woman.
|
2-3-minute video in which an empowered essential worker protagonist shares her COVID-19 related mental health problems and describes how she was able to confront her mental health problems and pursuit of mental health care, using language that speaks to the specific experience of being a young Latina woman
|
Experimental: Non-Adjusted Intervention Video
Participants will watch a 2-3-minute video in which an empowered essential worker protagonist shares her COVID-19 related mental health problems and describes how she was able to confront her mental health problems and pursuit of mental health care, without any language alluding to her particular identity characteristics.
|
2-3-minute video in which an empowered essential worker protagonist shares her COVID-19 related mental health problems and describes how she was able to confront her mental health problems and pursuit of mental health care, without any language alluding to her particular identity characteristics
|
No Intervention: Control Arm
Participants will watch a control video discussing daily activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stigma (3 items of the SSOSH-3)
Time Frame: 30 days after the intervention
|
Change in stigma items from baseline - higher score, indicate higher stigma (range of 3 to 12)
|
30 days after the intervention
|
Help Seeking Intentions (3 items of the ATSPPH)
Time Frame: 30 days after the intervention
|
Change in treatment seeking intentions from baseline - higher score, indicate higher help seeking intentions (range of 3 to 12)
|
30 days after the intervention
|
Stigma (the Self Stigma of Seeking Help Scale - 3 item) (SSOSH-3)
Time Frame: immediately after the intervention
|
Change in stigma items from baseline - higher score, indicate higher stigma (range of 3 to 12)
|
immediately after the intervention
|
Help Seeking Intentions (3 items of the Attitudes Toward Seeking Professional Psychological Help) (ATSPPH)
Time Frame: Immediately after the intervention
|
Change in treatment seeking intentions from baseline - higher score, indicate higher help seeking intentions (range of 3 to 12)
|
Immediately after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Referral Clicks
Time Frame: Immediately after the intervention
|
Number of clicks on link to referrals to mental health care provider database
|
Immediately after the intervention
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 8128a
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stigma, Social
-
Sheba Medical CenterCompleted
-
University of TorontoCompletedSocial StigmaLesotho, Swaziland
-
University of ChicagoPlanned Parenthood Federation of AmericaCompleted
-
Indiana UniversityCompletedStigma, Social | TransgenderismUnited States
-
Karolinska InstitutetUniversity of Nairobi; Moi UniversityCompletedPregnancy | Contraception | Social StigmaKenya
-
King's College LondonGroundswell; Lambeth Service Users Council; Museum of Homelessness; Inclusive InsightNot yet recruiting
-
Centre d'Higiene Mental Les CortsCompletedMental Health | Stigma, SocialSpain
-
RANDNational Alliance on Mental Illness CaliforniaRecruitingStigma, Social | Help-Seeking BehaviorUnited States
-
University College DublinCompletedStigma, Social | Well-Being | ShameIreland
-
Emory UniversityNational Institute of Nursing Research (NINR)Not yet recruitingPsychological Distress | Stigma, Social
Clinical Trials on Adjusted Content Intervention
-
University of CopenhagenCompleted
-
Evidation HealthBiomedical Advanced Research and Development AuthorityEnrolling by invitationCOVID-19 | Influenza | Influenza A | Respiratory Syncytial Virus (RSV) | Influenza BUnited States
-
University of MichiganNational Institute on Aging (NIA)TerminatedHeart FailureUnited States
-
Stanford UniversityCompleted
-
University of MichiganCompletedSubstance UseUnited States
-
Stanford UniversityWithdrawn
-
University Hospital of North NorwayLHL Helse; Helse NordCompletedCardiovascular DiseasesNorway
-
Baylor College of MedicineAgency for Healthcare Research and Quality (AHRQ)CompletedPrimary Care Patients With Chronic Conditions
-
Northwestern UniversityAnn & Robert H Lurie Children's Hospital of ChicagoActive, not recruiting
-
Harue HospitalCompleted